News and Announcements
- June 06, 2016
Newly launched Genomic Data Commons to facilitate data and clinical information sharing
The Genomic Data Commons (GDC) is a data sharing platform that promotes precision medicine in oncology, and it will host all of the TCGA data.
- May 09, 2016
Analysis of rare endocrine cancer reveals novel genetic alterations
In the most comprehensive molecular characterization to date of adrenocortical carcinoma, a rare cancer of the adrenal cortex, researchers extensively analyzed 91 cases for alterations in the tumor genomes.
- November 05, 2015
TCGA study identifies seven distinct subytypes of prostate cancer
A comprehensive analysis of 333 prostate cancers identified key genetic alterations that may help improve classification and treatment of the disease.
- November 04, 2015
Improved understanding of the genetic drivers of papillary renal cell carcinoma
A comprehensive genomic analysis of 161 tumors from people with papillary renal cell carcinoma (PRCC) – the second most common form of kidney cancer –provided insights into the molecular basis of this cancer and may inform its classification and treatment.
- October 08, 2015
TCGA study identifies genomic features of invasive lobular breast carcinoma
Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified molecular characteristics of a type of breast cancer, invasive lobular carcinoma (ILC), that distinguishes it from invasive ductal carcinoma (IDC), the most common invasive breast cancer subtype.
- June 18, 2015
TCGA study improves understanding of genetic drivers of cutaneous melanoma
A comprehensive analysis of the genome of cutaneous melanoma has provided new insights into the roles of frequently mutated cancer genes and other genomic alterations that drive the development of this disease.
- June 10, 2015
Genomic underpinnings of brain tumors expanded
TCGA researchers analyzed nearly 300 cases of diffuse low- and intermediate-grade gliomas, which together comprise lower-grade gliomas. LGGs occur mainly in adults and include astrocytomas, oligodendrogliomas and oligoastrocytomas.
- March 09, 2015
The Cancer Genome Atlas (TCGA): The next stage
The Cancer Genome Atlas (TCGA), the NIH research program that has helped set the standards for characterizing the genomic underpinnings of dozens of cancers on a large scale, is moving to its next phase.
- January 27, 2015
NIH-funded study uncovers range of molecular alterations in head and neck cancers, new potential drug targets
TCGA tumor genome sequencing analyses offer new insights into the effects of HPV and smoking, and find genomic similarities with other cancers.
- October 23, 2014
TCGA study improves understanding of genetic drivers of thyroid cancer
A comprehensive analysis of the genomes of nearly 500 papillary thyroid carcinomas has provided new insights into the roles of frequently mutated cancer genes and other genomic alterations that drive disease development.
1 2 3 Next >